Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors-Reference-Cited by-同舟云学术

Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors

Published:2008-12 Issue:6 Volume:17 Page:654-660
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Torrisi Rosalba,Dellapasqua Silvia,Ghisini Raffaella,Viale Giuseppe,Veronesi Paolo,Luini Alberto,Intra Mattia,Peruzzotti Giulia,Rocca Andrea,Balduzzi Alessandra,Cardillo Anna,Goldhirsch Aron,Colleoni Marco

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference35 articles.

1. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer;Powles;J Clin Oncol,1995

2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

3. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27;Bear;J Clin Oncol,2003

4. Recommendations from an International Expert Panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update;Kaufmann;J Clin Oncol,2006

5. Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesteron receptors;Colleoni;Ann Oncol,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial;Cancer;2019-03-20

2. METASTAZAVUSIO KRŪTIES VĖŽIO GYDYMAS TIK GERIAMAISIAIS CHEMOTERAPIJOS IR HORMONŲ TERAPIJOS PREPARATAIS;Medicinos teorija ir praktika;2017-01-20

3. The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial;Breast Cancer Research and Treatment;2011-10-16

4. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer;Breast Cancer Research and Treatment;2011-01-08

5. Preoperative therapy with trastuzumab and oral vinorelbine (± endocrine therapy) in patients with HER2-positive breast cancer;The Breast;2010-04